Autobio Strategically Cooperates with Pro-med in Thrombelastogram and POCT

On June 11, 2022, the signing ceremony of the strategic cooperation between Zhengzhou Autobio Diagnostics Co., Ltd. and Pro-med (Beijing) Technology Co., Ltd. was held in Zhengzhou, and the two parties officially launched the strategic cooperation.

The two parties signed a strategic cooperation agreement

Mr. Fu Guangyu, Executive Deputy General Manager of Autobio, said: "Pro-med has strong technical advantages and innovation capabilities in thrombelastogram, microfluidic photoconductive thromboelastogram, etc. Autobio is very pleased to cooperate with Pro-med. We hope that the two parties will work together to launch better products and services and contribute to human health.”

Mr. Wang Changqing, Deputy General Manager of Pro-med, said: "Autobio has a rich product line and deep technical accumulation, and has built a complete technology platform in the fields of immunity, microbiology, biochemistry, molecular, coagulation and other testing. We are very happy to carry out strategic cooperation with Autobio and hope to achieve complementary advantages and win-win cooperation through the joint efforts of the two parties, so as to better promote the development of China’s blood coagulation testing field."

After the signing ceremony, the two parties conducted extensive and in-depth exchanges on strategic cooperation. With this signing, the two parties will carry out strategic cooperation in thromboelastogram and POCT in the field of coagulation, and make full use of respective technical reserves and advantages to provide users with more abundant and complete product solutions.

Pro-med (Beijing) Technology Co., Ltd. was established in 2013 and has always been committed to providing end customers with integrated diagnostic solutions of "reagents + platforms + services". At present, it has covered the main IVD tracks such as coagulation, immunity and molecular diagnosis, and has built an excellent IVD enterprise with a systematic and comprehensive thromboelastogram detection scheme and precise cardiovascular diagnosis of women and children as the core.

In recent years, Autobio has carried out an in-depth layout in the field of coagulation, continuously enriching its product line, and hopes to form a closed-loop product in the field of coagulation testing in medical laboratories through efforts.